Sale!

SCN11A Gene Episodic pain syndrome type 3 familial Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SCN11A gene episodic pain syndrome type 3 familial genetic test is a specialized diagnostic procedure designed to identify mutations in the SCN11A gene, which are linked to the development of Familial Episodic Pain Syndrome Type 3 (FEPS3). This condition is characterized by episodes of severe pain without an apparent cause, affecting individuals from the same family, indicating a genetic basis. The SCN11A gene plays a crucial role in the transmission of pain signals in the nervous system, and mutations can lead to abnormal pain perception.

Conducted at DNA Labs UAE, a leading facility in genetic testing, this test offers a critical insight for affected individuals and their families, providing a definitive diagnosis of FEPS3. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific genetic alterations in the SCN11A gene that are known to cause the syndrome.

The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Obtaining a diagnosis through this test can be pivotal for affected individuals, as it not only helps in understanding the cause of their pain but also guides the management and treatment strategies to mitigate the symptoms, improving their quality of life. Additionally, the results can inform family planning decisions for those carrying the mutation.

Description

SCN11A Gene Episodic Pain Syndrome Type 3 Familial Genetic Test

Test Name: SCN11A Gene Episodic Pain Syndrome Type 3 Familial Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for SCN11A Gene Episodic Pain Syndrome Type 3, familial NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SCN11A Gene Episodic Pain Syndrome Type 3, familial.

Test Details:

The SCN11A gene is associated with episodic pain syndrome type 3, which is a rare genetic disorder characterized by recurring episodes of severe pain in the limbs, face, and/or torso. This pain can be triggered by various stimuli, such as touch, movement, or temperature changes.

NGS genetic testing of the SCN11A gene can identify mutations or variations in the gene that may be responsible for causing episodic pain syndrome type 3. This testing can be useful for individuals who have a family history of the condition or who are experiencing unexplained episodes of severe pain.

The results of this genetic test can help with diagnosis and may also inform treatment options and management strategies for individuals with episodic pain syndrome type 3. It is important to note that while genetic testing can provide valuable information, it is not a substitute for clinical evaluation and diagnosis by a healthcare professional.

Test Name	SCN11A Gene Episodic pain syndrome type 3 familial Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Neurological Disorders
Doctor	Neurologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for SCN11A Gene Episodic pain syndrome type 3, familial NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN11A Gene Episodic pain syndrome type 3, familial
Test Details	The SCN11A gene is associated with episodic pain syndrome type 3, which is a rare genetic disorder characterized by recurring episodes of severe pain in the limbs, face, and/or torso. This pain can be triggered by various stimuli, such as touch, movement, or temperature changes. NGS genetic testing of the SCN11A gene can identify mutations or variations in the gene that may be responsible for causing episodic pain syndrome type 3. This testing can be useful for individuals who have a family history of the condition or who are experiencing unexplained episodes of severe pain. The results of this genetic test can help with diagnosis and may also inform treatment options and management strategies for individuals with episodic pain syndrome type 3. It is important to note that while genetic testing can provide valuable information, it is not a substitute for clinical evaluation and diagnosis by a healthcare professional.